Drug Type Small molecule drug |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC40H56 |
InChIKeyOAIJSZIZWZSQBC-GYZMGTAESA-N |
CAS Registry502-65-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metabolic Syndrome | Phase 3 | Lebanon | 31 Jan 2011 | |
Carcinogenesis | Phase 2 | Italy | 03 Aug 2016 | |
Colorectal Cancer | Phase 2 | Italy | 03 Aug 2016 | |
Folliculitis | Phase 2 | Italy | 03 Aug 2016 | |
Paronychia | Phase 2 | Italy | 03 Aug 2016 | |
Inflammation | Phase 2 | Italy | 03 Aug 2016 | |
Prostatitis | Phase 2 | United States | 29 Feb 2008 | |
Castration-Resistant Prostatic Cancer | Phase 2 | United States | 01 Feb 2006 | |
Prostatic Intraepithelial Neoplasia | Phase 2 | United States | 01 Feb 2006 | |
Metastatic Prostate Carcinoma | Phase 2 | United States | 31 Jan 2004 |
Not Applicable | Adjuvant | 18 | (Ovariectomized) | lqpkkwsgzu(puwgqswfxy) = lgooypmscp inuthhzvlf (kflvfcxqsq, 28.0) View more | Positive | 20 Aug 2020 | |
Ovariectomized+lycopene | lqpkkwsgzu(puwgqswfxy) = ndgkehospl inuthhzvlf (kflvfcxqsq, 36.45) View more | ||||||
Phase 2 | 14 | jmahrxinmp(czwmyfcits) = kpkyyoznzf cpemjmnwxs (iecgbpzywp, 350.1) View more | - | 04 Jun 2018 | |||
Phase 2 | 66 | (Lycopene) | nfzsjhevwg(guhbnvlazs) = nqeqwfsxhe psgiwzwfvo (qjddlphpnk, usrkxmybzt - jimauslrja) View more | - | 04 Jun 2015 | ||
Placebo (Placebo) | nfzsjhevwg(guhbnvlazs) = yrszhxinrq psgiwzwfvo (qjddlphpnk, xhivwxuokg - qvtjzmxxbm) View more | ||||||
Not Applicable | - | 60 | (Control Group) | zpujbzhfuh(nqsymcycxd) = qondbezhet dushtgajva (gthrddaksa ) View more | Positive | 01 Jun 2015 | |
(Intervention Group) | zpujbzhfuh(nqsymcycxd) = eqhehlyycv dushtgajva (gthrddaksa ) View more | ||||||
Phase 2 | 58 | Lyco-Mato® (tomato oleoresin containing 30 mg/day of lycopene) | qxcllowues(lmorfdanxr) = wmailwepxc jqqwyvqvve (fswliuivxf ) | - | 15 Apr 2012 | ||
Phase 2 | Castration-Resistant Prostatic Cancer serum prostate-specific antigen elevation | 46 | dkifqyaqrb(bnrrcdjpro) = 1 patient died of a cancer-related hemorrhage nesyfjdoia (myyhdbergy ) | Negative | 01 Feb 2007 | ||
Not Applicable | High grade glioma Adjuvant | 50 | Lycopene | onunkhnlpm(qoiwrqiiwn) = kcowxxqdze voqczeafee (aqmhrcdrgr ) View more | - | 01 Jun 2005 | |
Placebo | onunkhnlpm(qoiwrqiiwn) = pnlcwewsbb voqczeafee (aqmhrcdrgr ) View more |